Decorin also suppresses bone metastasis in MDA-MB-231 breast cancer cells, and contributes to oppose cancer cell invasion as its stromal expression in breast invasive ductal carcinoma (IDC) is significantly weaker if compared to that in DCIS [93,94,95]. This evidence concerns the gene DCN and ductal breast carcinoma in situ.